<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2007-4085</journal-id>
<journal-title><![CDATA[Revista mexicana de urología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. mex. urol.]]></abbrev-journal-title>
<issn>2007-4085</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Urología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2007-40852018000600425</article-id>
<article-id pub-id-type="doi">10.24245/revmexurol.v78i6.2111</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Factores de riesgo asociados con infección de la vía urinaria provocada por superbacterias]]></article-title>
<article-title xml:lang="en"><![CDATA[Risk factors associated with developing urinary tract infections caused by superbugs]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Chavolla-Canal]]></surname>
<given-names><![CDATA[Alan Johan]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González-Mercado]]></surname>
<given-names><![CDATA[Mirna Gisel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,IMSS Hospital General Regional 46 Servicio de Urología]]></institution>
<addr-line><![CDATA[Guadalajara Jalisco]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Tecnológico de Monterrey División de Biotecnología y Salud ]]></institution>
<addr-line><![CDATA[Guadalajara Jalisco]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<volume>78</volume>
<numero>6</numero>
<fpage>425</fpage>
<lpage>433</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2007-40852018000600425&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2007-40852018000600425&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2007-40852018000600425&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  ANTECEDENTES:  En los últimos años ha tomado relevancia la aparición de resistencia panfarmacológica por superbacterias en pacientes con infección de la vía urinaria. Aunque se han descrito algunos factores de riesgo, son pocas las publicaciones al respecto.  OBJETIVO: Analizar en la población mexicana los factores de riesgo relacionados con infección de la vía urinaria provocada por superbacterias.  MATERIALES Y MÉTODOS: Estudio descriptivo y retrospectivo, en el que se analizaron los expedientes de urocultivos efectuados entre enero de 2007 y junio de 2015. Las variables de estudio fueron: sexo, edad, lugar de tratamiento, enfermedades relacionadas, antecedente de cirugías, servicio a cargo, razón de hospitalización, transfusión, tratamiento, portador de sonda urinaria, cultivo de control y defunción. Para el análisis de los datos se utilizó estadística descriptiva.  RESULTADOS: Se registraron 31 pacientes con infección de vías urinarias provocada por superbacterias. Pseudomonas aeruginosa fue el microorganismo aislado con mayor frecuencia, predominantemente en hombres y en pacientes de la tercera edad. Las enfermedades con mayor prevalencia fueron diabetes e hipertensión; el antecedente de transfusión y colocación de sonda urinaria representaron factores de riesgo asociados con la infección y tasa de mortalidad. Los antibióticos más prescritos fueron las cefalosporinas y la mortalidad general fue de 38.7%.  CONCLUSIÓN:  Ante la repercusión mundial de la resistencia panfarmacológica a los antibióticos hacen falta más estudios que contribuyan a disminuir la tasa de mortalidad. Este estudio proporciona información valiosa de los factores de riesgo asociados con infección de la vía urinaria por superbacterias.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  BACKGROUND:  The recent appearance of pandrug resistance due to superbugs has become relevant in patients with urinary tract infections. Some risk factors have been described, but there are few studies published on the topic.  AIM:  To analyze the risk factors related to urinary tract infections due to superbugs in the Mexican population.  MATERIALS AND METHODS:  In a descriptive, retrospective study, the medical records of patients that had urine cultures within the time frame of January 2007 to June 2015 were analyzed. The study variables were: sex, age, place of treatment, related diseases, prior surgeries, service in charge of the patient, reason for hospitalization, transfusion, treatment, indwelling urinary catheter, control culture, and death. Descriptive statistics were used for the data analysis.  RESULTS:  Thirty-one patients with superbug urinary infections were registered in the study. The most frequently isolated microorganism was Pseudomonas aeruginosa, predominating in men and advanced-age patients. Diabetes and high blood pressure were the most prevalent diseases. A history of transfusions and urinary catheter placement were risk factors associated with infection and mortality. Cephalosporins were the most widely prescribed antibiotics and the general mortality rate was 38.7%.  CONCLUSION:  More research is needed on this topic, given the worldwide impact of infections that are resistant to the majority of drugs on antibiotic panels. The present study provided valuable information on the risk factors associated with the devastating phenomenon of pandrug resistant infection caused by superbugs.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Factores de riesgo]]></kwd>
<kwd lng="es"><![CDATA[cultivo de control urinario]]></kwd>
<kwd lng="es"><![CDATA[superbacterias]]></kwd>
<kwd lng="es"><![CDATA[Pseudomonas aeruginosa]]></kwd>
<kwd lng="en"><![CDATA[Risk factors]]></kwd>
<kwd lng="en"><![CDATA[Control urine culture]]></kwd>
<kwd lng="en"><![CDATA[Superbugs]]></kwd>
<kwd lng="en"><![CDATA[Pseudomonas aeruginosa]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Solorzano]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evolution of the resistance to antibiotic of bacteria involved in urinary tract infections: A 7-year surveillance study]]></article-title>
<source><![CDATA[Am J Infect Control]]></source>
<year>2014</year>
<volume>42</volume>
<page-range>1033-8</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ankur-Tyagi]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Isolation and antibacterial susceptibility testing of multi drug resistant Pseudomonas aeruginosa causing urinary tract infections]]></article-title>
<source><![CDATA[J Chem Pharm Res]]></source>
<year>2011</year>
<volume>3</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>342-7</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>Secretaria de Salud</collab>
<source><![CDATA[Incidencia de infección de vías urinarias por grupos de edad. Estados Unidos Mexicanos 2014. Población General]]></source>
<year>2014</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodriguez-Noriega]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La evolución de la resistencia bacteriana en México, 1973-2013]]></article-title>
<source><![CDATA[Biomédica]]></source>
<year>2014</year>
<volume>34</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>181-90</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antibiotic resistance pattern of Pseudomonas aeruginosa isolated from urine samples of urinary tract infections patients in Karachi, Pakistan]]></article-title>
<source><![CDATA[Pak J Med Sci]]></source>
<year>2015</year>
<volume>2</volume>
<page-range>341-5</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Francesco]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in an Italian hospital]]></article-title>
<source><![CDATA[J Infect Public Health]]></source>
<year>2013</year>
<volume>6</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>179-85</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[SG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Multidrug and extensive drug resistance in Pseudomonas aeruginosa clinical isolates from a Portuguese central hospital: 10-yarsyear survey]]></article-title>
<source><![CDATA[Microb drug Resist]]></source>
<year>2015</year>
<volume>2</volume>
<page-range>194-200</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[OSSA-GIRALDO]]></surname>
<given-names><![CDATA[Ana Claudia]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de riesgo para infección por Pseudomonas aeruginosa multi-resistente en un hospital de alta complejidad]]></article-title>
<source><![CDATA[Rev Chil Infectol]]></source>
<year>2014</year>
<volume>31</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>393-9</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cornejo-Juárez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patrones de resistencia bacteriana en urocultivos en un hospital oncológico]]></article-title>
<source><![CDATA[Salud Pub Mex]]></source>
<year>2007</year>
<volume>49</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>330-6</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bjerklund-Johansen]]></surname>
<given-names><![CDATA[TE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of hospital-acquired urinary tract infections in urology departments]]></article-title>
<source><![CDATA[Eur Urol]]></source>
<year>2007</year>
<volume>51</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1100-11</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grabe]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guidelines on Urological Infections]]></article-title>
<source><![CDATA[European Association of Urology]]></source>
<year>2015</year>
<page-range>9-35</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McDougal]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Ewein]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Campbell-Walsh Urology]]></source>
<year>2012</year>
<edition>13</edition>
<page-range>257</page-range><publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[Saunders-Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Peña]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk-factors for acquisition of extended-spectrum b-lactamase-producing Escherichia coli among hospitalised patients]]></article-title>
<source><![CDATA[Clin Microbiol Infect]]></source>
<year>2006</year>
<volume>12</volume>
<page-range>279-84</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<collab>Clinical and Laboratory Standards Institute</collab>
<source><![CDATA[Performance standards for antimicrobial susceptibility testing; twenty-second information supplement]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Wayne(PA) ]]></publisher-loc>
<publisher-name><![CDATA[Clinical and Laboratory Standards Institute]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chavolla]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de bacterias aisladas con resistencia antibiótica extendida en los cultivos de orina durante 8 años en un hospital de segundo nivel en México]]></article-title>
<source><![CDATA[Rev Mex Urol]]></source>
<year>2016</year>
<volume>76</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>213-7</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
